Details of the Drug Formulaction

General Information of Drug Formulation (ID: F00750)

• Formulation Name: Alosetron 0.5 mg tablet
• Company: Actavis Pharma; Sebela Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Alosetron	(DML2A03)	Diarrhea-predominant irritable bowel syndrome	DD91.01	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Triacetin	(E00080)	5541	Humectant; Plasticizing agent; Solvent